Canada and the U.S. differ on ribavirin risk.
D000280:Administration, Inhalation; D000336:Aerosols / Q000009:adverse effects*; D002170:Canada; D005260:Female; D015386:Hazardous Substances / Q000009:adverse effects; D006801:Humans; D016273:Occupational Exposure / Q000517:prevention & control*; D010564:Personnel, Hospital / Q000592:standards*; D011247:Pregnancy; D012254:Ribavirin / Q000008:administration & dosage* / Q000633:toxicity; D014481:United States
D000336:Aerosols; D015386:Hazardous Substances; D012254:Ribavirin